The Metallodrug BOLD-100 Is a Potent Inhibitor of SARS-CoV-2 Replication and Has Broad-Acting Antiviral Activity

The COVID-19 pandemic has highlighted an urgent need to discover and test new drugs to treat patients. Metal-based drugs are known to interact with DNA and/or a variety of proteins such as enzymes and transcription factors, some of which have been shown to exhibit anticancer and antimicrobial effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Labach, Daniel S., Kohio, Hinissan P., Tse, Edwin A., Paparisto, Ermela, Friesen, Nicole J., Pankovich, Jim, Bazett, Mark, Barr, Stephen D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377621/
https://www.ncbi.nlm.nih.gov/pubmed/37509131
http://dx.doi.org/10.3390/biom13071095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377621/
https://www.ncbi.nlm.nih.gov/pubmed/37509131
http://dx.doi.org/10.3390/biom13071095

Ejemplares similares